BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 20445327)

  • 21. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia.
    Deshpande AJ; Cusan M; Rawat VP; Reuter H; Krause A; Pott C; Quintanilla-Martinez L; Kakadia P; Kuchenbauer F; Ahmed F; Delabesse E; Hahn M; Lichter P; Kneba M; Hiddemann W; Macintyre E; Mecucci C; Ludwig WD; Humphries RK; Bohlander SK; Feuring-Buske M; Buske C
    Cancer Cell; 2006 Nov; 10(5):363-74. PubMed ID: 17097559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes.
    Dik WA; Brahim W; Braun C; Asnafi V; Dastugue N; Bernard OA; van Dongen JJ; Langerak AW; Macintyre EA; Delabesse E
    Leukemia; 2005 Nov; 19(11):1948-57. PubMed ID: 16107895
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [CALM-AF10 fusion transcripts in primary leukemia with t(10;11) and in vitro chemotherapy sensitivity of leukemic cells with t(10;11)].
    Ou DM; Liu GX; Yan JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):770-3. PubMed ID: 15631658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of CALM-AF10 gene fusion in acute leukemia.
    Caudell D; Aplan PD
    Leukemia; 2008 Apr; 22(4):678-85. PubMed ID: 18094714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-color split signal fluorescence in situ hybridization assays for the detection of CALM/AF10 in t(10;11)(p13;q14-q21)-positive acute leukemia.
    La Starza R; Crescenzi B; Krause A; Pierini V; Specchia G; Bardi A; Nieddu R; Ariola C; Nanni M; Diverio D; Aventin A; Sborgia M; Martelli MF; Bohlander SK; Mecucci C
    Haematologica; 2006 Sep; 91(9):1248-51. PubMed ID: 16956826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute myeloid leukemia with t(10;11)(p11-12;q23.3): Results of Russian Pediatric AML registration study.
    Zerkalenkova E; Lebedeva S; Kazakova A; Tsaur G; Starichkova Y; Timofeeva N; Soldatkina O; Aprelova E; Popov A; Ponomareva N; Baidun L; Meyer C; Novichkova G; Maschan M; Maschan A; Marschalek R; Olshanskaya Y
    Int J Lab Hematol; 2019 Apr; 41(2):287-292. PubMed ID: 30624859
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice.
    Lange AP; Almeida LY; Araújo Silva CL; Scheucher PS; Chahud F; Krause A; Bohlander SK; Rego EM
    Braz J Med Biol Res; 2019; 52(6):e8424. PubMed ID: 31141090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute leukemia with PICALM-MLLT10 fusion gene: diagnostic and treatment struggle.
    Savage NM; Kota V; Manaloor EJ; Kulharya AS; Pierini V; Mecucci C; Ustun C
    Cancer Genet Cytogenet; 2010 Oct; 202(2):129-32. PubMed ID: 20875875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interstitial insertion of AF10 into the ALL1 gene in a case of infant acute lymphoblastic leukemia.
    Angioni A; La Starza R; Mecucci C; Sprovieri T; Matteucci C; De Rossi G; Balloni P; Cimino G
    Cancer Genet Cytogenet; 1998 Dec; 107(2):107-10. PubMed ID: 9844603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The target cell of transformation is distinct from the leukemia stem cell in murine CALM/AF10 leukemia models.
    Dutta S; Krause A; Vosberg S; Herold T; Ksienzyk B; Quintanilla-Martinez L; Tizazu B; Chopra M; Graf A; Krebs S; Blum H; Greif PA; Vetter A; Metzeler K; Rothenberg-Thurley M; Schneider MR; Dahlhoff M; Spiekermann K; Zimber-Strobl U; Wolf E; Bohlander SK
    Leukemia; 2016 May; 30(5):1166-76. PubMed ID: 26686248
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mixed-lineage leukemia with t(10;11)(p13;q21): an analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features.
    Kumon K; Kobayashi H; Maseki N; Sakashita A; Sakurai M; Tanizawa A; Imashuku S; Kaneko Y
    Genes Chromosomes Cancer; 1999 May; 25(1):33-9. PubMed ID: 10221337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the PZP domain of AF10 in acute leukemia driven by AF10 translocations.
    Klein BJ; Deshpande A; Cox KL; Xuan F; Zandian M; Barbosa K; Khanal S; Tong Q; Zhang Y; Zhang P; Sinha A; Bohlander SK; Shi X; Wen H; Poirier MG; Deshpande AJ; Kutateladze TG
    Nat Commun; 2021 Jul; 12(1):4130. PubMed ID: 34226546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear export signal within CALM is necessary for CALM-AF10-induced leukemia.
    Suzuki M; Yamagata K; Shino M; Aikawa Y; Akashi K; Watanabe T; Kitabayashi I
    Cancer Sci; 2014 Mar; 105(3):315-23. PubMed ID: 24397609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abrogation of MLL-AF10 and CALM-AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l.
    Chen L; Deshpande AJ; Banka D; Bernt KM; Dias S; Buske C; Olhava EJ; Daigle SR; Richon VM; Pollock RM; Armstrong SA
    Leukemia; 2013 Apr; 27(4):813-22. PubMed ID: 23138183
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The t(10;11) translocation in acute myeloid leukemia (M5) consistently fuses the leucine zipper motif of AF10 onto the HRX gene.
    Chaplin T; Bernard O; Beverloo HB; Saha V; Hagemeijer A; Berger R; Young BD
    Blood; 1995 Sep; 86(6):2073-6. PubMed ID: 7662954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A CALM-derived nuclear export signal is essential for CALM-AF10-mediated leukemogenesis.
    Conway AE; Scotland PB; Lavau CP; Wechsler DS
    Blood; 2013 Jun; 121(23):4758-68. PubMed ID: 23487024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myeloid leukemia driven by the CALM-AF10 fusion gene is dependent on BMI1.
    Barbosa K; Deshpande A; Chen BR; Ghosh A; Sun Y; Dutta S; Weetall M; Dixon J; Armstrong SA; Bohlander SK; Deshpande AJ
    Exp Hematol; 2019 Jun; 74():42-51.e3. PubMed ID: 31022428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute leukemias harboring KMT2A/MLLT10 fusion: a 10-year experience from a single genomics laboratory.
    Peterson JF; Sukov WR; Pitel BA; Smoley SA; Pearce KE; Meyer RG; Williamson CM; Smadbeck JB; Vasmatzis G; Hoppman NL; Greipp PT; Baughn LB; Ketterling RP
    Genes Chromosomes Cancer; 2019 Aug; 58(8):567-577. PubMed ID: 30707474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retroviral insertional mutagenesis identifies Zeb2 activation as a novel leukemogenic collaborating event in CALM-AF10 transgenic mice.
    Caudell D; Harper DP; Novak RL; Pierce RM; Slape C; Wolff L; Aplan PD
    Blood; 2010 Feb; 115(6):1194-203. PubMed ID: 20007546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and molecular characterisation of a CALM-AF10 fusion in acute megakaryoblastic leukaemia.
    Jones LK; Chaplin T; Shankar A; Neat M; Patel N; Samuel DP; Hill AS; Debernardi S; Bassini A; Young BD; Saha V
    Leukemia; 2001 Jun; 15(6):910-4. PubMed ID: 11417476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.